8-K
filed July 3, 2024, 7:59 PM ET
ticker TERN
CIK 0001831363
other
confidence high
sentiment neutral
materiality 0.15
Terns Pharmaceuticals extends office lease for 36 months through October 2027
Terns Pharmaceuticals, Inc.
- Lease extended from Nov 1, 2024 to Oct 31, 2027 for 9,751 sq ft in Foster City, CA.
- Monthly base rent: $0 (Nov '24-Jan '25), then $43,879.50 rising to $46,551.76 by 2026-27.
- Tenant pays $43,789.50 as prepaid rent for Feb 2025 upon execution of amendment.
- Option to extend for additional three years with 9-12 months written notice; first refusal right deleted.
- Landlord may convert building to life science lab; tenant gets rent abatement and termination rights for significant disruption.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0000950170-24-081531
- form_type
- 8-K
- ticker
- TERN
- cik
- 0001831363
- company_name
- Terns Pharmaceuticals, Inc.
- filed_at
- 2024-07-03T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:14.770923+00:00
- generated_at
- 2026-05-31T23:34:22.596645+00:00
- sec_items
- ["1.01", "2.03", "9.01"]
- event_type
- other
- sentiment
- neutral
- materiality_score
- 0.15
- calibrated_materiality_score
- 0.15
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0000950170-24-081531
- json_url
- https://secwatch.observer/filing/0000950170-24-081531.json
- markdown_url
- https://secwatch.observer/filing/0000950170-24-081531.md
- text_url
- https://secwatch.observer/filing/0000950170-24-081531.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1831363/000095017024081531/0000950170-24-081531-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1831363/000095017024081531/tern-20240701.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
PAL
Proficient Auto Logistics to attend William Blair conference; sets Q2 2026 earnings call for Aug 10
Proficient Auto Logistics, Inc
June 1, 2026, 5:29 PM ET
other
Items 7.01, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
REVB
Revelation Biosciences releases updated corporate presentation without disclosed details
REVELATION BIOSCIENCES, INC.
June 1, 2026, 5:26 PM ET
other
Items 8.01, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
XBP
XBP Global Holdings annual meeting elects directors, approves auditor and say-on-pay
XBP Global Holdings, Inc.
June 1, 2026, 5:00 PM ET
other
Items 5.07, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
SCHW
Charles Schwab files Certificate of Elimination for Series I Preferred Stock
SCHWAB CHARLES CORP
June 1, 2026, 5:00 PM ET
other
Items 5.03, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
CIVB
Civista Bancshares to present at conference; no material financial news disclosed
CIVISTA BANCSHARES, INC.
June 1, 2026, 5:00 PM ET
other
Items 7.01, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
CELH
Celsius Holdings to present at Deutsche Bank conference; no details disclosed
Celsius Holdings, Inc.
June 1, 2026, 4:26 PM ET
other
Items 7.01, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
CubeSmart, L.P.
CubeSmart files 8-K with investor slide presentation; no material new information disclosed
CubeSmart, L.P.
June 1, 2026, 4:22 PM ET
other
Items 2.02, 7.01, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
AXON
Axon shareholders elect all 9 director nominees and approve say-on-pay at 2026 annual meeting
AXON ENTERPRISE, INC.
June 1, 2026, 4:10 PM ET
other
Items 5.07, 9.01
same SEC item: 9.01
same event type: other
similar materiality
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.